Structures by: Pritchard R.
Total: 27
Urea-glutaric acid
C5H8O4,C1H4N2O1
CrystEngComm (2009) 11, 3 412
a=14.767(3)Å b=11.735(2)Å c=5.0741(10)Å
α=90° β=90° γ=90°
(1,8-Bis(5-methylsalicylaldiminato)-3,6-diazaoctane)iron(iii) hexafluorophosphate
C22H28FeN4O2,F6P
Dalton Transactions (2008) 24 3159-3168
a=10.3752(9)Å b=13.3931(11)Å c=19.3373(17)Å
α=107.903(4)° β=90.780(4)° γ=101.238(4)°
(1,8-Bis(2-hydroxy-1-naphthaldiminato)-3,6- diazaoctane)iron(iii) hexafluorophosphate diethylether solvate
C28H28FeN4O2,PF6,C4H10O
Dalton Transactions (2008) 24 3159-3168
a=14.1874(12)Å b=15.7976(13)Å c=29.091(3)Å
α=90.00° β=90.00° γ=90.00°
(1,8-Bis(5-tert-butylsalicylaldiminato)-3,6- diazaoctane)iron(iii) nitrate 1,2-dichloroethane solvate
C28H40FeN4O2,NO3,C2H4Cl2
Dalton Transactions (2008) 24 3159-3168
a=16.1177(7)Å b=21.6263(10)Å c=9.8296(7)Å
α=90.00° β=90.7226(19)° γ=90.00°
(1,8-Bis(salicylaldiminato)-3,6-diazaoctane)iron(iii) hexafluorophosphate
C20H24FeN4O2,F6P
Dalton Transactions (2008) 24 3159-3168
a=9.6187(12)Å b=27.768(3)Å c=18.009(2)Å
α=90.00° β=93.033(8)° γ=90.00°
(1,8-Bis(salicylaldiminato)-3,6-diazaoctane)iron(iii) hexafluorophosphate
C20H24FeN4O2,F6P
Dalton Transactions (2008) 24 3159-3168
a=9.5581(8)Å b=27.316(2)Å c=17.9457(15)Å
α=90.00° β=92.340(5)° γ=90.00°
2,6-bis(4-chloropyrazol-1-yl)pyridine
C11H7Cl2N5
Dalton Transactions (2009) 33 6656-6666
a=16.329(3)Å b=3.8130(7)Å c=20.215(3)Å
α=90.00° β=104.231(9)° γ=90.00°
2,6-bis(4-bromopyrazol-1-yl)pyridine
C11H7Br2N5
Dalton Transactions (2009) 33 6656-6666
a=16.1867(15)Å b=3.8789(3)Å c=20.1485(17)Å
α=90.00° β=103.757(3)° γ=90.00°
Bis[2,6-di(4-chloropyrazol-1-yl)pyridine]iron(II) ditetrafluoroborate
C22H14Cl4FeN10,2[BF4]
Dalton Transactions (2009) 33 6656-6666
a=17.1919(12)Å b=41.318(3)Å c=13.4331(10)Å
α=90.00° β=90.00° γ=90.00°
Bis[2,6-bis{4-iodopyrazol-1-yl}pyridine]iron(II) ditetrafluoroborate bis-acetone solvate
C22H14FeI4N10,2[BF4],2[C3H6O]
Dalton Transactions (2009) 33 6656-6666
a=11.4909(1)Å b=10.0039(1)Å c=35.3093(4)Å
α=90.00° β=90.6172(4)° γ=90.00°
Bis(2,6-bis(4-iodopyrazol-1-yl)pyridine)iron(ii) ditetrafluoroborate mono-acetone solvate
C22H14FeI4N10,2[BF4],C3H6O
Dalton Transactions (2009) 33 6656-6666
a=15.6789(2)Å b=16.5181(2)Å c=15.9708(2)Å
α=90.00° β=96.3400(10)° γ=90.00°
(1,8-Bis(salicylaldiminato)-3,6-diazaoctane)iron(iii) tetraphenylborate hemi-(1,2-dichloroethane) solvate
C20H24FeN4O2,C24H20B,0.5[C2H4Cl2]
Dalton Transactions (2008) 24 3159-3168
a=26.180(5)Å b=10.750(2)Å c=28.620(6)Å
α=90.00° β=102.09(3)° γ=90.00°
(1,8-Bis(salicylaldiminato)-3,6-diazaoctane)iron(iii) perchlorate
C20H24FeN4O2,ClO4
Dalton Transactions (2008) 24 3159-3168
a=17.8864(15)Å b=13.7970(11)Å c=27.951(3)Å
α=90.00° β=100.881(5)° γ=90.00°
(1,8-Bis(salicylaldiminato)-3,6-diazaoctane)iron(iii) tetraphenylborate hemi-acetone solvate
C20H24FeN4O2,C24H20B,0.5[C3H6O]
Dalton Transactions (2008) 24 3159-3168
a=25.977(2)Å b=10.8833(12)Å c=28.562(3)Å
α=90.00° β=103.321(5)° γ=90.00°
C22H36O3
C22H36O3
Dalton transactions (Cambridge, England : 2003) (2013) 42, 40 14438-14444
a=20.1799(12)Å b=14.7239(8)Å c=6.9459(4)Å
α=90° β=96.932(2)° γ=90°
C98H150Cu2N2O12
C98H150Cu2N2O12
Dalton transactions (Cambridge, England : 2003) (2013) 42, 40 14438-14444
a=10.8423(5)Å b=11.7031(7)Å c=19.1273(13)Å
α=94.023(2)° β=92.903(2)° γ=104.049(2)°
C47H38Cl2N10Ni2O8
C47H38Cl2N10Ni2O8
Journal of the Chemical Society, Dalton Transactions (1999) 13 2211
a=12.739(3)Å b=14.266(3)Å c=14.699(3)Å
α=77.00(3)° β=84.61(3)° γ=63.04(3)°
C28.5H25ClN6NiO4
C28.5H25ClN6NiO4
Journal of the Chemical Society, Dalton Transactions (1999) 13 2211
a=20.993(4)Å b=20.649(4)Å c=16.821(3)Å
α=90.00° β=122.32(2)° γ=90.00°
Bis(2,6-di(4-bromopyrazol-1-yl)pyridine)iron(ii) ditetrafluoroborate
C22H14Br4FeN10,2[BF4]
Chemical communications (Cambridge, England) (2007) 6 577-579
a=9.7615(1)Å b=9.7615(1)Å c=17.2273(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(2,6-di(4-chloropyrazol-1-yl)pyridine)iron(ii) ditetrafluoroborate
C22H14Cl4FeN10,2[BF4]
Chemical communications (Cambridge, England) (2007) 6 577-579
a=9.5613(1)Å b=9.5613(1)Å c=17.3177(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(2,6-di(4-chloropyrazol-1-yl)pyridine)iron(ii) ditetrafluoroborate
C22H14Cl4FeN10,2[BF4]
Chemical communications (Cambridge, England) (2007) 6 577-579
a=9.5410(3)Å b=9.5410(3)Å c=17.1024(6)Å
α=90.00° β=90.00° γ=90.00°
Bis(2,6-di(4-chloropyrazol-1-yl)pyridine)iron(ii) ditetrafluoroborate
C22H14Cl4FeN10,2[BF4]
Chemical communications (Cambridge, England) (2007) 6 577-579
a=9.6268(3)Å b=9.6508(3)Å c=16.5051(5)Å
α=90.00° β=90.7285(12)° γ=90.00°
Bis[hydroxybis(pyridin-2-yl)methanesulfonato- κ^3^<i>N</i>,<i>O</i>,<i>N</i>]cobalt(II)
C22H18Co1N4O8S2
Acta Crystallographica Section C (2013) 69, 1 21-24
a=7.7300(3)Å b=9.3475(4)Å c=15.6518(6)Å
α=90° β=98.499(2)° γ=90°
Bis[hydroxybis(pyridin-2-yl)methanesulfonato- κ^3^<i>N</i>,<i>O</i>,<i>N</i>]copper(II) hexahydrate
C22H18Cu1N4O8S2,6(H2O)
Acta Crystallographica Section C (2013) 69, 1 21-24
a=7.5892(3)Å b=10.1399(4)Å c=10.7325(5)Å
α=108.675(2)° β=109.920(2)° γ=101.025(4)°
Bis(methyltri-<i>o</i>-tolylphosphonium) octaiodide
2(C22H24P1),I82
Acta Crystallographica Section C (2011) 67, 7 o219-o221
a=9.6680(2)Å b=12.3567(3)Å c=12.8186(4)Å
α=62.3640(10)° β=76.4100(10)° γ=73.0730(10)°
Μ-hydrogen-bis[tris(4-fluorophenyl)phosphane oxide] triiodide
C36H25F6O2P2,I3
Acta Crystallographica Section C (2012) 68, 6 o216-o219
a=13.2153(4)Å b=15.9752(6)Å c=18.5695(6)Å
α=90° β=108.818(2)° γ=90°
Kapellasite
Cl2.18Cu3H5.82O5.82Zn
Mineralogical Magazine (2006) 70, 329-340
a=6.300Å b=6.300Å c=5.733Å
α=90° β=90° γ=120°